These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 11720077)
1. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials. Tripathi AK; Gupta A; Garg SK; Tekwani BL Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077 [TBL] [Abstract][Full Text] [Related]
2. A physiochemical mechanism of hemozoin (beta-hematin) synthesis by malaria parasite. Tripathi AK; Garg SK; Tekwani BL Biochem Biophys Res Commun; 2002 Jan; 290(1):595-601. PubMed ID: 11779214 [TBL] [Abstract][Full Text] [Related]
4. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay. Tekwani BL; Walker LA Comb Chem High Throughput Screen; 2005 Feb; 8(1):63-79. PubMed ID: 15720198 [TBL] [Abstract][Full Text] [Related]
5. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. Pandey AV; Tekwani BL; Singh RL; Chauhan VS J Biol Chem; 1999 Jul; 274(27):19383-8. PubMed ID: 10383451 [TBL] [Abstract][Full Text] [Related]
6. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization. Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844 [TBL] [Abstract][Full Text] [Related]
13. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds. Ncokazi KK; Egan TJ Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752 [TBL] [Abstract][Full Text] [Related]
14. A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallization. Ma W; Balta VA; West R; Newlin KN; Miljanić OŠ; Sullivan DJ; Vekilov PG; Rimer JD J Biol Chem; 2021; 296():100123. PubMed ID: 33239360 [TBL] [Abstract][Full Text] [Related]
15. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs]. Xue J; Jiang B; Liu CS; Sun J; Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850 [TBL] [Abstract][Full Text] [Related]
16. Identification of β-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity. Sandlin RD; Fong KY; Wicht KJ; Carrell HM; Egan TJ; Wright DW Int J Parasitol Drugs Drug Resist; 2014 Dec; 4(3):316-25. PubMed ID: 25516843 [TBL] [Abstract][Full Text] [Related]
17. Identification of β-hematin inhibitors in the MMV Malaria Box. Fong KY; Sandlin RD; Wright DW Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923 [TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials. Peters W; Fleck SL; Robinson BL; Stewart LB; Jefford CW Ann Trop Med Parasitol; 2002 Sep; 96(6):559-73. PubMed ID: 12396319 [TBL] [Abstract][Full Text] [Related]
19. Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs. Witkowski B; Lelièvre J; Nicolau-Travers ML; Iriart X; Njomnang Soh P; Bousejra-Elgarah F; Meunier B; Berry A; Benoit-Vical F PLoS One; 2012; 7(3):e32620. PubMed ID: 22403683 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of new antimalarial agents from 4-aminoquinoline. Solomon VR; Puri SK; Srivastava K; Katti SB Bioorg Med Chem; 2005 Mar; 13(6):2157-65. PubMed ID: 15727868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]